Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abbreviated, abdominal, alanine, Alex, alongside, ALT, aminotransferase, Anderson, artificial, aspartate, AST, automated, Azar, begun, charitable, chest, circulation, cleared, CMML, Colorado, concurrent, construed, coordinated, Delta, departure, deregulated, developmental, diarrhea, domain, dossier, driven, elucidate, equivalent, erasure, exempted, fat, FDPIC, feasible, febrile, feedback, flat, FTC, House, HTA, hypertension, hypertensive, inconsistent, intelligence, justifying, licensure, liposarcoma, lodge, milademetan, moment, myelomonocytic, NaN, narrowly, nausea, neutropenia, notify, occasion, officially, organizational, pain, Portability, postmarketing, ransomware, rash, recentlypublished, recipient, reinstate, rolling, Secretary, shipment, SM, soft, spike, Statute, supplementary, suspected, Telephone, therewith, threat, transmissible, turnover, underwriting, Vanderbilt, variant, Virginia, waived, White, York
Removed:
AA, activated, adenocarcinoma, advancing, AEs, AGA, Alabama, androgenetic, assessing, ATI, AU, barrier, Birmingham, brain, breast, carcinoma, cessation, checkpoint, cohort, compare, composite, comprehensive, confirmed, cytarabine, discovered, dosed, dosing, Ebola, elderly, enveloped, erlotinib, evolution, exhibited, favorably, Foundation, GBM, glioblastoma, hair, Ichiro, immuglobulin, initiative, Interferon, KEYTRUDA, KeytrudaTM, LDAC, leave, magnitude, medically, moderate, Nakano, Neurosurgery, noncompliant, noted, pembrolizumab, PFS, Professor, profile, Quantitative, recurrent, regimen, resection, salesforce, scalp, score, Southampton, surface, surgical, Survival, Tarceva, thromboembolic, tolerated, topical, triple, uncovered, underway, unsatisfied, unusual, Vitiligo, Zika
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view